Skip to main content

Table 6 Factors associated with service use in the 12 months of life, N = 68,523

From: Primary care service use by end-of-life cancer patients: a nationwide population-based cohort study in the United Kingdom

Variable Value GP consultationa   GP prescriptionb  
Palliative care Yes 1.30(1.29 to 1.32) < 0.0001 1.17(1.16 to 1.18) < 0.0001
Age at death (ref: < 50) 50–59 0.98(0.95 to 1.01) < 0.0001 1.09(1.04 to 1.13) < 0.0001
60–69 0.97(0.95 to 1.00)   1.21(1.16 to 1.25)  
70–79 0.95(0.93 to 0.98)   1.26(1.22 to 1.31)  
80–89 0.90(0.88 to 0.93)   1.28(1.23 to 1.33)  
90+ 0.85(0.83 to 0.88)   1.34(1.29 to 1.40)  
Gender (ref: female) Male 0.96(0.95 to 0.97) < 0.0001 0.93(0.91 to 0.94) < 0.0001
Cancer site (ref: Lung) Colorectal 1.01(1.00 to 1.03) < 0.0001 1.06(1.04 to 1.08) < 0.0001
Breast 1.04(1.03 to 1.05)   0.97(0.96 to 0.99)  
Prostate 1.22(1.20 to 1.24)   1.15(1.13 to 1.17)  
No. comorbidity conditions (ref: 0) 1 1.09(1.08 to 1.11) < 0.0001 1.20(1.18 to 1.22) < 0.0001
2 1.21(1.19 to 1.22)   1.43(1.40 to 1.45)  
3 1.30(1.28 to 1.32)   1.62(1.59 to 1.65)  
4+ 1.42(1.39 to 1.44)   1.92(1.88 to 1.95)  
Time between diagnosis and death (months) (ref: 120+) < 6 1.06(1.03 to 1.09) < 0.0001 0.99(0.95 to 1.02)  
6–12 1.27(1.23 to 1.31)   1.09(1.05 to 1.12) < 0.0001
13–36 1.09(1.06 to 1.11)   1.06(1.03 to 1.10)  
37–60 1.04(1.01 to 1.07)   1.04(1.01 to 1.07)  
61–120 1.00(0.97 to 1.03)   1.00(0.97 to 1.03)  
Year of death (ref: 2010–2014) 2000–2004 0.63(0.61 to 0.65) < 0.0001 0.82(0.81 to 0.84) < 0.0001
2005–2009 0.87(0.85 to 0.88)   0.93(0.91 to 0.94)  
Region (ref: England) Wales 0.98(0.92 to 1.04) < 0.0001 1.14(1.09 to 1.19) < 0.0001
Scotland 1.13(1.06 to 1.20)   0.98(0.94 to 1.02)  
NI 1.57(1.43 to 1.71)   1.15(1.07 to 1.24)  
  1. a including all consultations (i.e. direct & indirect patient contacts); bprescriptions of unique products only